MCB-22-174
Based on 1 Customer Validation
MCB-22-174 is a deuterated Piezo1 agonist, with an EC50 value of 6.28 μM. MCB-22-174 remarkably activates the CaMKII/ERK signaling pathway and initiates Ca2+ influx in rMSCs. MCB-22-174 significantly decreases the expression of chondrogenesis markers (Comp, Acan) and adipogenesis markers (Lpl, Fabp4) in MSCs. MCB-22-174 can effectively improve bone quality in hind-limb unloading (HU) model rats. MCB-22-174 can be used for the study of disuse osteoporosis (OP).
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit : 99.78%
- CAS. Nr.: 3058199-58-6
- Formel: C16H14DCl2N5OS2
- Molecular Weight:429.37
-
Speicherung:Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
- Protokoll
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Biologische Aktivität
Beschreibung
In Vitro
MCB-22-174 (0-40 μM) exhibits potent agonistic activity on Piezo1 in C3H10T1/2 cells with an EC50 value of 6.28 μM[1].
MCB-22-174 (3-5 μM, 72 h) significantly upregulates the mRNA level of Runx2 in rMSCs and promotes osteogenesis more effectively than Yoda1 (HY-18723)[1].
MCB-22-174 (5 μM, 5-15 min) remarkably upregulates p-ERK and p-CaMKII in rMSCs, and activates the CaMKII/ERK signaling pathway more efficiently than Yoda1[1].
MCB-22-174 (5 μM) significantly decreases the expression of chondrogenesis markers (Comp, Acan) and adipogenesis markers (Lpl, Fabp4) in MSCs, showing a more significant suppression of chondrogenesis and adipogenesis than Yoda1[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:SD rats (2-month-old) were subjected to hind-limb unloading by tail suspension, with their tails fixed on the upper lids of cages to detach the hind limbs from the ground (forelimbs unaffected), simulating weightlessness to induce disuse osteoporosis[1]
-
Dosage:2 mg/kg (5 μmol/kg)
-
Administration:Intraperitoneally injected on days 1, 4, 7, 10, and 13
-
Result:Improved bone quality in HU model rats.
Upregulated bone volume ratio (BV/TV) and trabecular thickness (Tb.Th.).
Downregulated trabecular separation (Tb.Sp.).
Increased the fluorescent area of alkaline phosphatase (ALP).
Promoted osteogenesis, with better efficacy than Yoda1.
Anwendung
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
CAS. Nr. 3058199-58-6
-
Unlabeled CAS 3087134-90-2
-
Appearance Solid
-
Molecular Weight 429.37
-
Formel C16H14DCl2N5OS2
-
Color Off-white to light yellow
-
SMILES
ClC(C=CC=C1Cl)=C1C([2H])SC2=NN=C(C3=NC=C(NC[C@H](O)C)N=C3)S2
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years In solvent -80°C 6 months -20°C 1 month
Reinheit & Dokumentation
-
Data Sheet (273 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Verweise
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
MCB-22-174 Related Classifications
HY-165607S Related Classifications
Powered by Bioz